Potassium Asparaginate/Magnesium Asparaginate Tender - 139231455

Procurement Summary

Country: Ukraine

Summary: Potassium Asparaginate/Magnesium Asparaginate Solution for Injections of 5 Ml; Hydroxyethyl Starch (Average Molecular Weight 200, 000), 6%, 200 Ml Each; Hydroxyethyl Starch (Average Molecular Weight 200, 000), 6%, P...

Deadline: 12 Apr 2026

Posting Date: 09 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139231455

Document Ref. No.: UA-2026-04-08-000803-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 630000

CPV Classification

33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Potassium asparaginate/Magnesium asparaginate solution for injections of 5 ml; Hydroxyethyl starch (average molecular weight 200, 000), 6%, 200 ml each; Hydroxyethyl starch (average molecular weight 200, 000), 6%, 400 ml each; Suxamethonium, solution for injection, 20 mg/ml, 5 each ml; Meropenem, powder for injections/infusions, 1 g each; Sodium chloride, solution for infusions, 9 mg/ml 100 ml; Ethyl alcohol 96% 100 ml.; Metamizole sodium 500 mg/ml pitophenone hydrochloride 2 mg/ml fenpiverinium bromide 0.02 mg/ml, solution for injection, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Cefotaxime, powder for injections of 1 g; Ceftriaxone, powder for injections of 1 g; Gentamicin, solution for injection, 40 mg/ml, 2 ml each; Lincomycin solution for injection 300 mg/ml in 2 ml; Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g; Human anti-D immunoglobulin, solution for injection, 300 mcg (1500 IU)/2 ml, 2 ml each; Ketorolac solution for injection, 30 mg/ml, 1 ml each; Chlorhexidine, solution for external use 0.05% per 100 ml; Decametoxin, solution, 0.2 mg/ml, 200 ml each; Ceftazidime, powder for injection 2.0 g; Dexamethasone, solution for injection 4mg/ml; Diclofenac solution for injection 25 mg/ml; Omeprazole 40 mg capsules; Diclofenac gel/ointment 50 mg/g per 50 g; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Urapidil solution for injection 5 mg/ml in 5 ml Purchase type: goods Classifier and its corresponding code: DC 021:2015: 33600000-6 — Pharmaceutical products Meropenem, powder for injections/infusions, 1 g each; Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of the active substance: 0.05%, Volume: 100 ml, Packaging type: Vial Name Classifier and its corresponding code Quantity/Units of delivery Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Meropenem, powder for injections/infusions, 1 g each; Classification a...

Documents

 Tender Notice